Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Intangibles (2022 - 2025)

Historic Intangibles for GeneDx Holdings (WGS) over the last 4 years, with Q3 2025 value amounting to $172.6 million.

  • GeneDx Holdings' Intangibles rose 646.43% to $172.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.6 million, marking a year-over-year increase of 646.43%. This contributed to the annual value of $158.6 million for FY2024, which is 812.45% down from last year.
  • Per GeneDx Holdings' latest filing, its Intangibles stood at $172.6 million for Q3 2025, which was up 646.43% from $176.7 million recorded in Q2 2025.
  • GeneDx Holdings' Intangibles' 5-year high stood at $193.7 million during Q2 2022, with a 5-year trough of $155.1 million in Q1 2025.
  • For the 4-year period, GeneDx Holdings' Intangibles averaged around $174.4 million, with its median value being $174.4 million (2023).
  • Data for GeneDx Holdings' Intangibles shows a peak YoY increase of 668.79% (in 2025) and a maximum YoY decrease of 829.3% (in 2025) over the last 5 years.
  • Over the past 4 years, GeneDx Holdings' Intangibles (Quarter) stood at $186.6 million in 2022, then decreased by 7.51% to $172.6 million in 2023, then fell by 8.12% to $158.6 million in 2024, then rose by 8.82% to $172.6 million in 2025.
  • Its last three reported values are $172.6 million in Q3 2025, $176.7 million for Q2 2025, and $155.1 million during Q1 2025.